FOR RESEARCH & EDUCATIONAL PURPOSES ONLY - NOT MEDICAL ADVICE
PeptaBaseBack to Database
Growth Factor

IGF-1

Typical Dosage
50-100 mcg
Administration
Injection
Half-Life
Native free IGF-1 is short; protein-bound exposure is longer

Mechanism of Action

Anabolism and growth studies|Tissue repair|Glucose metabolism|Muscle and bone research

Research Protocol Summary

Evidence Level
Human Clinical / Marketed
Typical Protocol Duration
4-12 weeks
Species Studied
Human • Mouse • Rat
Administration Schedule
Daily

Studies

Research Availability

Individual PubMed records have not been mapped for this entry yet. Use the linked PubMed search to review the current literature directly.

Open PubMed Search
Related resources
Growth FactorEditorial PolicyEvidence MethodologyResearch GlossaryPeptide ComparisonsPeptide Calculator

Research Feedback

0 approved

For research discussion only. Community feedback is moderated and shown here as aggregated insights after approval.

Loading approved insights…

Related Peptides

IGF-1 LR3
Growth Factor
PEG-MGF
Growth Factor